SCHEMBL30174107

SCHEMBL30174107

COCOc1ccc(-c2cc(=O)c3c(O)c(I)c(OCOC)cc3o2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 3/20 0.56
▸ MAPT P10636 4/20 0.52
▸ POLB P06746 3/20 0.52
▸ MEN1 O00255 3/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ OPRD1 P41143 2/20 0.52
▸ NPC1 O15118 2/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ KIT P10721 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ NFKB2 Q00653 1/20 0.52
▸ RELA Q04206 1/20 0.52
▸ ADORA3 P0DMS8 1/20 0.52
▸ QPCT Q16769 1/20 0.51
▸ MAOB P27338 4/20 0.50
▸ CYP19A1 P11511 1/20 0.50
▸ ABCB1 P08183 3/20 0.49
▸ ABCG2 Q9UNQ0 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1976134 0.83 FLT3 (0.76) FLT3MAPTPOLBMEN1KMT2A
SCHEMBL30174079 0.81 TUBB4A (0.50) MAPTPOLBMEN1KMT2AADORA3
SCHEMBL29074005 0.80 ABCB1 (0.65) FLT3MAPTMEN1KMT2AKDM4E
SCHEMBL30577294 0.80 ABCB1 (0.65) FLT3MAPTMEN1KMT2AKDM4E
SCHEMBL23383379 0.78 MAPT (0.64) FLT3MAPTPOLBMEN1KMT2A
SCHEMBL15245959 0.77 FLT3 (0.74) FLT3MAPTPOLBMEN1KMT2A
SCHEMBL30577296 0.77 CREB1 (0.69) FLT3MAPTPOLBMEN1KMT2A
SCHEMBL29149099 0.77 ABCB1 (0.61) FLT3MAPTPOLBMEN1KMT2A
SCHEMBL29074013 0.77 CREB1 (0.69) FLT3MAPTPOLBMEN1KMT2A
SCHEMBL30730485 0.77 ABCB1 (0.61) FLT3MAPTPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4367121-A1 COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF Centre National de la Recherche Scientifique (FR) 2024-05-15 — — EP claimed
WO-2023280746-A1 COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-01-12 — — WO claimed
US-20240425515-A1 COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF CENTRE NAT RECH SCIENT (FR) 2024-12-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240425515-A1 COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF HK1, HK2, C1R FLT3 3325/4885MAPT 4606/4885POLB 3170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback